Cargando…
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin
Tuberous sclerosis complex (TSC) results from loss of a tumor suppressor gene - TSC1 or TSC2, encoding hamartin and tuberin, respectively. These proteins formed a complex to inhibit mTORC1-mediated cell growth and proliferation. Loss of either protein leads to overgrowth lesions in many vital organs...
Autores principales: | Cheah, Pike-See, Prabhakar, Shilpa, Yellen, David, Beauchamp, Roberta L., Zhang, Xuan, Kasamatsu, Shingo, Bronson, Roderick T., Thiele, Elizabeth A., Kwiatkowski, David J., Stemmer-Rachamimov, Anat, György, Bence, Ling, King-Hwa, Kaneki, Masao, Tannous, Bakhos A., Ramesh, Vijaya, Maguire, Casey A., Breakefield, Xandra O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793581/ https://www.ncbi.nlm.nih.gov/pubmed/33523984 http://dx.doi.org/10.1126/sciadv.abb1703 |
Ejemplares similares
-
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1
por: Prabhakar, Shilpa, et al.
Publicado: (2019) -
AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice
por: Prabhakar, Shilpa, et al.
Publicado: (2021) -
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
por: Prabhakar, Shilpa, et al.
Publicado: (2022) -
In vivo tomographic imaging of red-shifted fluorescent proteins
por: Deliolanis, Nikolaos C., et al.
Publicado: (2011) -
Correction: Stochastic Model of Tsc1 Lesions in Mouse Brain
por: Prabhakar, Shilpa, et al.
Publicado: (2013)